SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
阿卡波糖拌饭
Lv1
2
90 积分
2024-07-23 加入
科研新手,请多指教!
最近求助
最近应助
互助留言
Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer
1小时前
待确认
CDK7 in breast cancer: mechanisms of action and therapeutic potential
1小时前
已完结
Advances in synthesis and biological evaluation of CDK2 inhibitors for cancer therapy
1小时前
已完结
Targeting cyclin-dependent kinase 2 CDK2: Insights from Molecular Docking and Dynamics Simulation- A systematic computational approach to discover novel cancer therapeutics
2小时前
已完结
Cyclin-Dependent Kinase 2 (CDK2) Inhibitors and others novel CDK Inhibitors (CDKi) in Breast Cancer: Clinical Trials, Current Impact, and Future Directions
2小时前
已完结
Inhibitors and PROTACs of CDK2: challenges and opportunities
2小时前
已完结
Impact of Problem-Based Learning on Clinical Skills in Oncology Education
29天前
已关闭
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
1个月前
已完结
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
1个月前
已完结
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial
1个月前
已完结
没有进行任何应助
速度真快,感谢,点赞,帮大忙了,么么哒
1小时前
速度真快,感谢,感谢,帮大忙了,么么哒
1小时前
感谢,点赞,速度真快,帮大忙了,,么么哒
2小时前
速度真快,感谢,点赞,帮大忙了,么么哒
2小时前
ai编的【积分已退回】
29天前
感谢,么么哒
1个月前
速度真快,帮大忙了,感谢,么么哒
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论